clinical topic updates

Novel Therapies and Investigational Agents for Myelofibrosis
Oncology

Novel Therapies and Investigational Agents for Myelofibrosis

clinical topic updates
By Stephen T. Oh, MD, PhD
From Initiation to Discontinuation: Managing Multiple Sclerosis With High-Efficacy Disease-Modifying Therapies
Neurology

From Initiation to Discontinuation: Managing Multiple Sclerosis With High-Efficacy Disease-Modifying Therapies

clinical topic updates
By Robert A. Bermel, MD, MBA
Risk Factors for the Development of Tardive Dyskinesia
Psychiatry

Risk Factors for the Development of Tardive Dyskinesia

clinical topic updates
By Joohi Jimenez-Shahed, MD
The Reversibility of Tardive Dyskinesia
Psychiatry

The Reversibility of Tardive Dyskinesia

clinical topic updates
By Leslie Citrome, MD, MPH
Anti-infective Prophylactic Strategies for Patients With Chronic Lymphocytic Leukemia in the Current Treatment Era
Oncology

Anti-infective Prophylactic Strategies for Patients With Chronic Lymphocytic Leukemia in the Current Treatment Era

clinical topic updates
By Alessandra Ferrajoli, MD
Load More